Our study was aimed to evaluate the risk of a selected non-motor symptom, namely rapid eye movement behavior disorder symptoms, among patients with newly diagnosed Parkinson disease compared with health controls. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines for meta-analysis and Cochrane manual were followed.